AstraZeneca vaccine scientists set for £22m payday in New York float
over 4 years in The guardian
Sarah Gilbert, Adrian Hill and Oxford University to get windfalls when Covid vaccine firm Vaccitech goes public
Coronavirus – latest updates
See all our coronavirus coverage
Prof Sarah Gilbert, the Oxford University scientist who lead the team that created the Oxford/AstraZeneca coronavirus vaccine, is set for a payday of more than £20m as the vaccine technology firm she co-founded prepares to float on the New York stock exchange.
Gilbert, who became a household name as a result of her work creating Oxford’s Covid-19 vaccine, owns just over 5% of Vaccitech, a Oxford University spin-out company that owns the biotechnology behind the AstraZeneca coronavirus vaccine and others for Mers, hepatitis B, the virus that causes shingles, and a range of cancers. Continue reading...